Eli Lil­ly sued by for­mer em­ploy­ees al­leg­ing age dis­crim­i­na­tion, cit­ing hir­ing prac­tices fa­vor­ing in­terns

4 years ago
Pharma

Bris­tol My­ers li­cens­es for Evotec mol­e­cule for $20M; FDA ap­proves Im­pel's mi­graine nasal spray Trud­he­sa

4 years ago
News Briefing

Mod­er­na's boost­er plan comes in­to fo­cus with pre-print stud­ies in im­muno­com­pro­mised pop­u­la­tions, Delta break­throughs

4 years ago
Coronavirus

Cas­sa­va CEO goes on the of­fen­sive over da­ta al­le­ga­tions, shout­ing down 'short at­tack'

4 years ago
R&D

Pri­vate eq­ui­ty, sov­er­eign wealth fund al­ly on an $8B buy­out aimed at tak­ing rare dis­ease play­er pri­vate

4 years ago
Deals

The long-over­looked safe­ty is­sue weigh­ing on the FDA’s mind on day 1 of marathon gene ther­a­py meet­ing

4 years ago
Cell/Gene Tx
FDA+

Sis­ter to Juno's liso-cel, JW's rel­ma-cel lands sec­ond-ever CAR-T ap­proval in Chi­na

4 years ago
China
Cell/Gene Tx

Covid-19 roundup: Glax­o­SmithK­line man­dates vac­cines as lat­est phar­ma to join the push; South Africa's As­pen wants to ...

4 years ago
Coronavirus

No­var­tis scut­tles tri­al for pro­gram laud­ed by Vas Narasimhan as emerg­ing trans­plant drug star

4 years ago
R&D

'Sig­nif­i­cant ques­tions re­main' on ap­proval of Bio­gen's new Alzheimer's drug, con­gres­sion­al com­mit­tees tell FDA

4 years ago
FDA+

Zio­pharm finds new CEO af­ter six-month search; CFO tran­si­tion at Lon­za to take place in De­cem­ber

4 years ago
Peer Review

Forte Bio­sciences shares col­lapse af­ter lead bac­te­ria drug flops key eczema study

4 years ago
R&D

Hot off of a $210M Se­ries B, Umo­ja breaks ground in Col­orado on CAR-T site

4 years ago
Manufacturing

As bank­rupt­cy neared, work­ers at a US­An­tibi­otics site worked un­til the lights went out. Now, the site will get a ...

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Stain­less steel iden­ti­fied as for­eign item in Japan­ese Mod­er­na lots; DoD con­tract ...

4 years ago
Coronavirus
Manufacturing

Build­ing on man­u­fac­tur­ing com­mit­ment, BioN­Tech meets with African lead­ers

4 years ago
Manufacturing

Re­call re­port: Lo­cal anes­thet­ic from Teligent deemed too po­tent

4 years ago
Manufacturing

In­novent and Gen­Fleet reach deal for KRAS in­hibitor; TCR2 re­ceives FDA's ODD on ga­vo-cel

4 years ago
News Briefing

Sack­lers win im­mu­ni­ty from opi­oid law­suits as Pur­due Phar­ma is dis­solved in bank­rupt­cy set­tle­ment

4 years ago
People
Pharma

As­sem­bly Bio ditch­es he­pati­tis B drug on liv­er tox­i­c­i­ty con­cerns in mid-stage test

4 years ago
R&D

6 key clin­i­cal tri­al trends that we should em­brace and build on

4 years ago
Biotech Voices

FDA ap­proves BeiGene's Brukin­sa in rare blood can­cer amid com­pa­ny's US ex­pan­sion plans

4 years ago
Pharma
FDA+

Amid med­dling con­cerns, FDA con­venes ad­comm for Pfiz­er/BioN­Tech boost­er

4 years ago
Coronavirus

Scoop: In­spired by the late Tachi Ya­ma­da, Jim Wil­son launch­es new non­prof­it tar­get­ing un­der­served ul­tra-rare dis­eases

4 years ago
People
Pharma
First page Previous page 643644645646647648649 Next page Last page
A service from the Financial Times